Form 8-K - Current report:
SEC Accession No. 0001354488-13-000513
Filing Date
2013-02-08
Accepted
2013-02-08 16:04:59
Documents
4
Period of Report
2013-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT immy_8k.htm 8-K 33129
2 UNDERWRITING AGREEMENT immy_ex11.htm EX-1.1 299834
3 CERTIFICATE OF AMENDMENT immy_ex31.htm EX-3.1 10482
4 PRESS RELEASE immy_ex991.htm EX-99.1 12584
  Complete submission text file 0001354488-13-000513.txt   357548
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 13586821
SIC: 2834 Pharmaceutical Preparations